Lung Cancer Screening Improvement Collaborative

This Collaborative of the ACR® Learning Network seeks to significantly increase lung cancer screening volumes.

Join the Next Cohort

Lung cancer is the leading cause of cancer death in the U.S., and currently up to 90% of eligible patients do not receive a low-dose computed tomography (LDCT) scan. If lung cancer is caught before it spreads, the likelihood of surviving 5 years or more improves to 61%, but only 4.5% of those who are eligible were screened in 2022. To increase screening volumes, participating facilities are supported in identifying and evaluating opportunities within scheduling processes, data collection and reporting, provider relationships, patient communication, and patient navigator responsibilities.

Start your application

ACR Learning Network Lung Cancer Screening Quality Improvement Collaborative

Problem Statement

Lung Cancer Screening programs are underutilized by patients, possibly leading to missed opportunities for early cancer detection and management.

How the Collaborative Works

Each facility forms an interdisciplinary project team consisting of four to six members who participate in the ACR® ImPower Program, alongside a cohort of colleagues from other institutions. Together, these teams will receive quality improvement (QI) education and utilize QI tools to identify and test ways to increase lung cancer screening volumes.

Suggested team members:

Radiologist with a thoracic imaging clinical focus.
Program navigator or coordinator.
CT supervisor/manager or technologist.
Primary care leader/champion.
Patient scheduler.

Learn how to participate

Collaborative Committee Chair

Neville Irani, MD

Founder of the Healthcare Quality Improvement Platform

Collaborative Committee

Stephen Sevigny, MD
Ayis Pyrros, MD
Terrance Healey, MD
Sara Ghandehari, MD

Link Up With the Learning Network

We’re here to help your team succeed. Please reach out with any questions to the ACR Learning Network team.

Request support